According to the company, amlodipine benazepril is indicated for the treatment of hypertension in patients not adequately controlled with either agent and is taken once daily. Dr Reddy’s product is available in bottles of 100 count capsules.

In September 2009, Dr Reddy’s had entered into a patent settlement with Novartis on amlodipine benazepril stipulating the dismissal of the lawsuits in the US. The US Food & Drug Administration (USFDA) granted an approval of the company's ANDA for amlodipine benazepril on April 15, 2010.

Will the new launch benefit the firm?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.